|
Thursday 5th August 2010 |
Text too small? |
Ebos Group is selling its trans-Tasman science businesses, allowing the medical products supplier to erase its debt. Shares of Ebos rose to a three-month high.
The Christchurch-based company sold its Global Science and Technology, Quantum Scientific and Crown Scientific units to Pennsylvania-based lab supply and distribution company VWR International.
The deal will leave Ebos “essentially debt free,” the company said.
As at December 31, the company had some $70 million in bank debt, according to its first half report.
“The transaction will be value-positive for Ebos shareholders both in terms of a gain on sale from the transaction and the resultant cash flow,” the company said in a statement.
“Ebos intends to utilise its full financial resources to focus on and grow in the healthcare market exclusively.”
The shares rose 1.1% to $6.50 in trading today, and have outperformed the NZX 50 this year, gaining 10% compared to the index’s 5.6% decline. As at December 31, the scientific businesses’ assets were worth $40.8 million.
The units made up 4% of Ebos’ first-half revenue at $30.3 million, though the $2.5 million underlying earnings made up 11% of EBITDA.
Businesswire.co.nz
No comments yet
Ebos still hungry for acquisitions after $1.1 bln Symbion deal, Waller says
Ebos meets prospectus forecast with 5.5 percent gain in FY profit
Ebos shareholders approve $1.1 billion purchase of Symbion
Ebos grabs scale with $1.1 bln purchase of Aussie pharma distributor Symbion
Ebos kicks tyres on potential acquisitions
Ebos lifts profit by 19%, targets growth in animal health
Ebos funding line smaller than previously flagged at $135 mln
Ebos Group
Ebos backs off British purchase, evaluates "significant" Australasian asset
Ebos reports higher profit, looks for acquisitions
